Cardiocore Consortium Wins 10-Year, $20B National Institutes of Health Contract
09.July.2012; Washington, DC-Cardiocore, a premier centralized cardiac testing laboratory and technology provider, announced today that its consortium has been awarded the coveted Chief Information Officer-Solutions and Partners 3 (CIO-SP3) Government Wide Acquisition Contract (GWAC). This contract, sponsored by the National Institutes of Health (NIH), is valued at $20 billion over a 10-year term.
Led by Creative Information Technology (CITI), Cardiocore’s team also includes ICON Medical Imaging and Zimmerman Associates (ZAI). These organizations are joined through a Contractor Team Agreement (CTA). In total, the NIH’s CIO-SP3 indefinite delivery/indefinite quantity (ID/IQ) program comprises approximately 50 contractors, serving a wide range of government agencies, with particular focus on Biomedical Research, Health Sciences, and Healthcare work orders.
"We are very pleased that our team has been selected by the NIH for this landmark CIO-SP3 award," said Scott Satin, Cardiocore’s Vice President of Marketing. "We look forward to expanding our NIH and other government-sponsored services in the decade ahead, and we are delighted to be part of such a well-qualified, well-experienced coalition."
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
